Amal Therapeutics completes venture financing

Amal Therapeutics S.A., Geneva, Switzerland Business: Cancer Date completed: 2016-03-30 Type: Venture financing Raised: CHF3 million ($3.1 million) Investors: Boehringer Ingelheim Venture Fund; VI Par...